A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival

Keith N. Ogston, Iain D. Miller, Simon Payne, +5

The Breast

Surgical OncologyBreast OncologyPathologyCancer RegistrationPrognostic Significance +15

Ki67 is a Graded Rather than a Binary Marker of Proliferation versus Quiescence

Iain D. Miller, Mingwei Min, Chen Yang, +4

Cell Reports

Neoadjuvant Chemotherapy in Breast Cancer: Significantly Enhanced Response With Docetaxel

Ian C. P. Smith, Steven D. Heys, Andrew W. Hutcheon, +9

Journal of Clinical Oncology

Breast OncologyCancer ManagementPharmacotherapyCancer ChemotherapyCpr Rate +16

Positron Emission Tomography Using [¹⁸F]-Fluorodeoxy-<scp>d</scp>-Glucose to Predict the Pathologic Response of Breast Cancer to Primary Chemotherapy

Ian C. P. Smith, A. Welch, Andrew W. Hutcheon, +10

Journal of Clinical Oncology

Surgical OncologyEngineeringBreast OncologyOncologic ImagingPathology +15

Neoadjuvant Docetaxel in Breast Cancer: 3-Year Survival Results from the Aberdeen Trial

Steven D. Heys, Andrew W. Hutcheon, Tarun K. Sarkar, +6

Clinical Breast Cancer

Breast OncologyOncologyBreast CancerNeoadjuvant DocetaxelCancer Treatment +3

Profiling Cytochrome <i>P</i>450 Expression in Ovarian Cancer: Identification of Prognostic Markers

Diane L. Downie, Morag McFadyen, Patrick H. Rooney, +6

Clinical Cancer Research

Profiling the expression of cytochrome P450 in breast cancer

Graeme I. Murray, Siva Patimalla, Keith N. Stewart, +2

Histopathology

Staging of the Axilla in Breast Cancer

Ian C. P. Smith, Keith N. Ogston, Phillipa Whitford, +8

Annals of Surgery

Control of the Restriction Point by Rb and p21

Justin Moser, Iain D. Miller, Dylan Carter, +1

Proceedings of the National Academy of Sciences

Immunohistochemical Localization of Cytochrome P450 CYP1B1 in Breast Cancer with Monoclonal Antibodies Specific for CYP1B1

Morag McFadyen, Suzanne Breeman, Simon Payne, +4

Journal of Histochemistry & Cytochemistry